- Home
- KGEI vs ORMP Comparison
KGEI vs ORMP Comparison
Compare KGEI & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KGEI | ORMP |
|---|---|---|
| Founded | 2008 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.3M | 141.3M |
| IPO Year | 2009 | 2010 |
Fundamental Metrics
Financial Performance| Metric | KGEI | ORMP |
|---|---|---|
| Price | $5.49 | $3.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 204.7K | 142.9K |
| Earning Date | 03-19-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 7.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.26 |
| Revenue | N/A | ★ $1,340,000.00 |
| Revenue This Year | $4.35 | N/A |
| Revenue Next Year | $24.69 | N/A |
| P/E Ratio | $7.94 | ★ $2.71 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.35 | $1.82 |
| 52 Week High | $9.31 | $3.76 |
Technical Indicators
Market Signals| Indicator | KGEI | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 69.51 | 52.15 |
| Support Level | $5.18 | $3.21 |
| Resistance Level | $5.68 | $3.72 |
| Average True Range (ATR) | 0.32 | 0.15 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 85.71 | 60.96 |
Price Performance
Historical ComparisonAbout KGEI Kolibri Global Energy Inc.
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.